DECIPHERA PHARMACEUTICALS IN (DCPH) Forecast, Price Target & Analyst Ratings

NASDAQ:DCPH • US24344T1016

Current stock price

25.59 USD
+0.02 (+0.08%)
At close:
25.61 USD
+0.02 (+0.08%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DECIPHERA PHARMACEUTICALS IN (DCPH).

Forecast Snapshot

Consensus Price Target

Price Target
$27.25
+ 6.47% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 7, 2024
Period
Q2 / 2024
EPS Estimate
-$0.52
Revenue Estimate
50.622M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
71.25%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$27.25
Upside
+ 6.47%
From current price of $25.59 to mean target of $27.25, Based on 16 analyst forecasts
Low
$25.86
Median
$26.52
High
$31.50

Price Target Revisions

1 Month
1.26%
3 Months
17.06%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for DCPH. The average price target is 27.25 USD. This implies a price increase of 6.47% is expected in the next year compared to the current price of 25.59.
The average price target has been revised upward by 17.06% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

DCPH Current Analyst RatingDCPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

DCPH Historical Analyst RatingsDCPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
71.25%
DCPH was analyzed by 16 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about DCPH.
In the previous month the buy percentage consensus was at a similar level.
DCPH was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-04-30GuggenheimDowngrade Buy -> Neutral
2024-04-30JMP SecuritiesDowngrade Market Outperform -> Market Perform
2024-04-30BarclaysUpgrade Underweight -> Equal-Weight
2024-04-29JonesTradingDowngrade Buy -> Hold
2024-04-29JefferiesDowngrade Buy -> Hold
2024-03-20JP MorganMaintains Neutral -> Neutral
2024-02-07StifelMaintains Buy -> Buy
2023-11-20JP MorganReiterate Neutral
2023-10-31JonesTradingUpgrade Hold -> Buy
2023-10-31StifelMaintains Buy -> Buy
2023-10-31HC Wainwright & Co.Maintains Buy -> Buy
2023-10-30Piper SandlerUpgrade Neutral -> Overweight
2023-08-10StifelUpgrade Hold -> Buy
2023-08-10HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-05JMP SecuritiesReiterate Market Outperform
2023-05-04JMP SecuritiesReiterate Market Outperform
2023-03-15JMP SecuritiesReiterate Market Outperform
2023-02-08SVB LeerinkReiterate Outperform
2023-02-08HC Wainwright & Co.Reiterate Buy
2023-02-07SVB LeerinkMaintains Outperform
2023-01-25Cowen & Co.Maintains Outperform
2023-01-06JonesTradingUpgrade Sell -> Hold
2023-01-04GuggenheimUpgrade Neutral -> Buy
2023-01-04SVB LeerinkMaintains Outperform
2023-01-04BarclaysMaintains Underweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 7, 2024
Period
Q2 / 2024
EPS Estimate
-$0.52
Revenue Estimate
50.622M
Revenue Q2Q
32.16%
EPS Q2Q
9.33%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
2.15%
Revenue (3 Months)
1.70%
EPS (1 Month)
9.43%
EPS (3 Months)
8.94%

Next Earnings Summary

DCPH is expected to report earnings on 8/7/2024. The consensus EPS estimate for the next earnings is -0.52 USD and the consensus revenue estimate is 50.62M USD.
The next earnings revenue estimate has been revised upward by 1.7% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
DCPH revenue by date.DCPH revenue by date.
96.148M
128.45%		134.036M
39.41%		163.356M
21.87%		205.66M
25.90%		264.6M
28.66%		382.46M
44.54%		434.31M
13.56%		509.33M
17.27%		610.88M
19.94%		715.74M
17.17%		1.039B
45.16%
EBITDA
YoY % growth
DCPH ebitda by date.DCPH ebitda by date.
-297.063M
-10.48%		-179.776M
39.48%		-208.858M
-16.18%		-206.04M
1.35%		-208.08M
-0.99%		-184.62M
11.27%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
DCPH ebit by date.DCPH ebit by date.
-300.077M
-10.65%		-182.722M
39.11%		-210.958M
-15.45%		-203.205M
3.68%		-168.305M
17.17%		-73.214M
56.50%		-25.102M
65.71%		53.931M
314.85%		157.78M
192.56%		267.94M
69.82%		538.56M
101.00%
Operating Margin
DCPH operating margin by date.DCPH operating margin by date.
-312.10%-136.32%-129.14%-98.81%-63.61%-19.14%-5.78%10.59%25.83%37.44%51.83%
EPS
YoY % growth
DCPH eps by date.DCPH eps by date.
-5.15
-7.52%		-2.55
50.49%		-2.29
10.20%		-2.17
5.08%		-1.59
27.06%		-0.59
63.05%		-0.45
23.82%		0.71
258.29%		1.58
123.83%		2.60
64.52%		4.04
55.29%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.52
9.33%		-0.53
9.15%		-0.55
-1.16%		-0.47
9.77%		-0.44
15.13%		-0.33
38.06%		-0.08
85.06%
Revenue
Q2Q % growth		50.622M
32.16%		53.839M
24.30%		54.858M
13.59%		49.556M
16.47%		55.699M
10.03%		68.122M
26.53%		89.5M
63.15%
EBITDA
Q2Q % growth		-49.98M
3.13%		-51M
2.01%		-54.06M
-10.02%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-49.106M
6.95%		-49.524M
7.76%		-52.484M
-2.43%		-49.558M
-1.45%		-46.642M
5.02%		-35.814M
27.68%		-12.61M
75.97%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DCPH Yearly Revenue VS EstimatesDCPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
DCPH Yearly EPS VS EstimatesDCPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
20.37%
EPS Next 5 Year
18.21%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
32.58%
Revenue Next 5 Year
25.42%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
4.87%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

DECIPHERA PHARMACEUTICALS IN / DCPH Forecast FAQ

What is the price target for DCPH stock?

16 analysts have analysed DCPH and the average price target is 27.25 USD. This implies a price increase of 6.47% is expected in the next year compared to the current price of 25.59.

When does DECIPHERA PHARMACEUTICALS IN (DCPH) report earnings?

DECIPHERA PHARMACEUTICALS IN (DCPH) will report earnings on 2024-08-07, before the market open.

What are the consensus estimates for DECIPHERA PHARMACEUTICALS IN (DCPH) next earnings?

The consensus EPS estimate for the next earnings of DECIPHERA PHARMACEUTICALS IN (DCPH) is -0.52 USD and the consensus revenue estimate is 50.62M USD.

Can you provide the analyst count for DECIPHERA PHARMACEUTICALS IN stock?

The number of analysts covering DECIPHERA PHARMACEUTICALS IN (DCPH) is 16.